{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:00:02Z","timestamp":1794294002937,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CSL Centenary Fellow"},{"name":"Wellcome Trust Senior Fellow in Clinical Science","award":["200909"],"award-info":[{"award-number":["200909"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Reducing the risk of recurrent\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      malaria is critical for malaria control and elimination. Primaquine (PQ) is the only widely available drug against\n                      <jats:italic>P. vivax<\/jats:italic>\n                      dormant liver stages, but is recommended as a 14-day regimen, which can undermine adherence to a complete course of treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a mixed-methods study to assess socio-cultural factors influencing adherence to a 14-day PQ regimen in a 3-arm, treatment effectiveness trial in Papua, Indonesia. The qualitative strand, consisting of interviews and participant observation was triangulated with a quantitative strand in which trial participants were surveyed using a questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Trial participants differentiated between two types of malaria:\n                      <jats:italic>tersiana<\/jats:italic>\n                      and\n                      <jats:italic>tropika<\/jats:italic>\n                      , equivalent to\n                      <jats:italic>P. vivax<\/jats:italic>\n                      and\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      infection, respectively. The perceived severity of both types was similar with 44.0% (267\/607) perceiving\n                      <jats:italic>tersiana<\/jats:italic>\n                      vs. 45.1% (274\/607) perceiving\n                      <jats:italic>tropika<\/jats:italic>\n                      as more severe. There was no perceived differentiation whether malaria episodes were due to a new infection or relapse; and 71.3% (433\/607) acknowledged the possibility of recurrence. Participants were familiar with malaria symptoms and delaying health facility visit by 1\u20132 days was perceived to increase the likelihood of a positive test. Prior to health facility visits, symptoms were treated with leftover drugs kept at home (40.4%; 245\/607) or bought over the counter (17.0%; 103\/607). Malaria was considered to be cured with \u2018blue drugs\u2019 (referring to dihydroartemisinin-piperaquine). Conversely, \u2018brown drugs,\u2019 referring to PQ, were not considered malaria medication and instead were perceived as supplements. Adherence to malaria treatment was 71.2% (131\/184), in the supervised arm, 56.9% (91\/160) in the unsupervised arm and 62.4% (164\/263) in the control arm; p\u2009=\u20090.019. Adherence was 47.5% (47\/99) among highland Papuans, 51.7% (76\/147) among lowland Papuans, and 72.9% (263\/361) among non-Papuans; p\u2009&lt;\u20090.001.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adherence to malaria treatment was a socio-culturally embedded process during which patients (re-)evaluated the characteristics of the medicines in relation to the course of the illness, their past experiences with illness, and the perceived benefits of the treatment. Structural barriers that hinder the process of patient adherence are crucial to consider in the development and rollout of effective malaria treatment policies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-023-04578-3","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T03:02:02Z","timestamp":1684551722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study"],"prefix":"10.1186","volume":"22","author":[{"given":"Annisa","family":"Rahmalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Rini","family":"Poespoprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra U. R.","family":"Landuwulang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Ronse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enny","family":"Kenangalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustina H.","family":"Burdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Peeters Grietens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Gryseels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"4578_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the era of the shrinking P. falciparum map. Trends Parasitol. 2020;36:560\u201370.","journal-title":"Trends Parasitol"},{"key":"4578_CR2","unstructured":"WHO. World Malaria Report 2019. Geneva. World Health Organization, 2019."},{"key":"4578_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","volume":"16","author":"K Thriemer","year":"2017","unstructured":"Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16:141.","journal-title":"Malar J"},{"key":"4578_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1475-2875-10-351","volume":"10","author":"D Fernando","year":"2011","unstructured":"Fernando D, Rodrigo C, Rajapakse S. Primaquine in vivax malaria: an update and review on management issues. Malar J. 2011;10:351.","journal-title":"Malar J"},{"key":"4578_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1475-2875-11-280","volume":"11","author":"GK John","year":"2012","unstructured":"John GK, Douglas NM, Von Seidlein L, Nosten F, Baird JK, White NJ, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012;11:280.","journal-title":"Malar J"},{"key":"4578_CR6","doi-asserted-by":"publisher","first-page":"e1003494","DOI":"10.1371\/journal.pmed.1003494","volume":"18","author":"K Thriemer","year":"2021","unstructured":"Thriemer K, Ley B, von Seidlein L. Towards the elimination of Plasmodium vivax malaria: implementing the radical cure. PLoS Med. 2021;18:e1003494.","journal-title":"PLoS Med"},{"key":"4578_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-12-112","volume":"12","author":"L Von Seidlein","year":"2013","unstructured":"Von Seidlein L, Auburn S, Espino FE, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.","journal-title":"Malar J"},{"key":"4578_CR8","unstructured":"WHO. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria. Geneva. World Health Organization, 2016."},{"key":"4578_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/14787210.2016.1220304","volume":"14","author":"CS Chu","year":"2016","unstructured":"Chu CS, White NJ. Management of relapsing Plasmodium vivax malaria. Expert Rev Anti Infect Ther. 2016;14:885\u2013900.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4578_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12916-016-0611-9","volume":"14","author":"CC John","year":"2016","unstructured":"John CC. Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk. BMC Med. 2016;14:65.","journal-title":"BMC Med"},{"key":"4578_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4269\/ajtmh.2010.09-0521","volume":"82","author":"K Peeters Grietens","year":"2010","unstructured":"Peeters Grietens K, Soto V, Erhart A, Muela Ribera J, Toomer E, Tenorio A, et al. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the peruvian Amazon. Am J Trop Med Hyg. 2010;82:1017\u201323.","journal-title":"Am J Trop Med Hyg"},{"key":"4578_CR12","doi-asserted-by":"publisher","first-page":"e84555","DOI":"10.1371\/journal.pone.0084555","volume":"9","author":"K Bruxvoort","year":"2014","unstructured":"Bruxvoort K, Goodman C, Kachur SP, Schellenberg D. How patients take malaria treatment: asystematic review of the literature on adherence to antimalarial drugs. PLoS One. 2014;9:e84555.","journal-title":"PLoS One"},{"key":"4578_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12936-022-04047-3","volume":"21","author":"DM Saint-Gerons","year":"2022","unstructured":"Saint-Gerons DM, Rodovalho S, Barros Dias \u00c1L, de Carvalho A, Beratarrechea ALU, Monteiro WM, et al. Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth. Malar J. 2022;21:28.","journal-title":"Malar J"},{"key":"4578_CR14","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/s41598-021-81468-1","volume":"11","author":"F Jaiteh","year":"2021","unstructured":"Jaiteh F, Okebe J, Masunaga Y, D\u2019Alessandro U, Achan J, Gryseels C, et al. Understanding adherence to reactive treatment of asymptomatic malaria infections in the Gambia. Sci Rep 2021;11:1746.","journal-title":"Sci Rep"},{"key":"4578_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.actatropica.2015.08.008","volume":"152","author":"A Cheoymang","year":"2015","unstructured":"Cheoymang A, Ruenweerayut R, Muhamad P, Rungsihirunrat K, Na-Bangchang K. Patients\u2019 adherence and clinical effectiveness of a 14-day course of primaquine when given with a 3-day chloroquine in patients with Plasmodium vivax at the Thai-Myanmar border. Acta Trop. 2015;152:151\u20136.","journal-title":"Acta Trop"},{"key":"4578_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1475-2875-10-355","volume":"10","author":"EA Pereira","year":"2011","unstructured":"Pereira EA, Ishikawa EA, Fontes CJ. Adherence to Plasmodium vivax malaria treatment in the brazilian Amazon Region. Malar J. 2011;10:355","journal-title":"Malar J"},{"key":"4578_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308.","journal-title":"Malar J"},{"key":"4578_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1473-3099(21)00358-3","volume":"22","author":"JR Poespoprodjo","year":"2022","unstructured":"Poespoprodjo JR, Burdam FH, Candrawati F, Ley B, Meagher N, Kenangalem E, et al. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster randomised, controlled, open-label superiority trial. Lancet Infect Dis. 2022;22:367\u201376.","journal-title":"Lancet Infect Dis"},{"key":"4578_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12936-021-03732-z","volume":"20","author":"A Fehr","year":"2021","unstructured":"Fehr A, Nieto-Sanchez C, Muela J, Jaiteh F, Ceesay O, Maneh E, et al. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in the Gambia. Malar J. 2021;20:198.","journal-title":"Malar J"},{"key":"4578_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12936-016-1193-x","volume":"15","author":"J Muela Ribera","year":"2016","unstructured":"Muela Ribera J, Hausmann-Muela S, Gryseels C, Peeters Grietens K. Re-imagining adherence to treatment from the \u201cother side\u201d: local interpretations of adverse anti-malarial drug reactions in the peruvian Amazon. Malar J. 2016;15:136.","journal-title":"Malar J"},{"key":"4578_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12936-016-1588-8","volume":"15","author":"M Karyana","year":"2016","unstructured":"Karyana M, Devine A, Kenangalem E, Burdarm L, Poespoprodjo JR, Vemuri R, et al. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia. Malar J. 2016;15:536.","journal-title":"Malar J"},{"key":"4578_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4269\/ajtmh.17-0680","volume":"98","author":"A Devine","year":"2018","unstructured":"Devine A, Kenangalem E, Burdam FH, Anstey NM, Poespoprodjo JR, Price RN, et al. Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin- piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia. Am J Trop Med Hyg. 2018;98:543\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"4578_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00006199-199103000-00014","volume":"40","author":"JM Morse","year":"1991","unstructured":"Morse JM. Approaches to qualitative-quantitative methodological triangulation. Nurs Res. 1991;40:120\u20133.","journal-title":"Nurs Res"},{"key":"4578_CR24","volume-title":"Theory construction and model-building skills: a practical guide for social scientists","author":"J Jaccard","year":"2010","unstructured":"Jaccard J, Jacoby J. Theory construction and model-building skills: a practical guide for social scientists. New York, Guilford Press; 2010."},{"key":"4578_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1163\/15718115-02401004","volume":"24","author":"II Hadiprayitno","year":"2017","unstructured":"Hadiprayitno II. The limit of narratives: ethnicity and indigenous rights in Papua, Indonesia. Int J Minor Gr Rights. 2017;24:1\u201323.","journal-title":"Int J Minor Gr Rights"},{"key":"4578_CR26","unstructured":"Upton S. The impact of migration on the people of Papua, Indonesia. A historical demographic analysis. University of New South Wales. 2009."},{"key":"4578_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4000\/books.pacific.938","volume-title":"Pathways of change","author":"A Ploeg","year":"2020","unstructured":"Ploeg A. Pathways of change. Marseille: Pacific-Credo Publications; 2020. 163 p."},{"key":"4578_CR28","first-page":"592","volume-title":"Guns, germs and steel: a short history of everybody for the last 13,000 years","author":"J Diamond","year":"1998","unstructured":"Diamond J. Guns, germs and steel: a short history of everybody for the last 13,000 years. Surrey: Vintage; 1998. 592 p."},{"key":"4578_CR29","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1080\/1369183X.2018.1561252","volume":"46","author":"I Auwalin","year":"2020","unstructured":"Auwalin I. Ethnic identity and internal migration decision in Indonesia. J Ethn Migr Stud. 2020;46:2841\u201361.","journal-title":"J Ethn Migr Stud"},{"key":"4578_CR30","doi-asserted-by":"publisher","first-page":"e1002379","DOI":"10.1371\/journal.pmed.1002379","volume":"14","author":"NM Douglas","year":"2017","unstructured":"Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, et al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med. 2017;14:e1002379.","journal-title":"PLoS Med"},{"key":"4578_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5172\/rsj.19.3.211","volume":"19","author":"V Petkova-Timmer","year":"2009","unstructured":"Petkova-Timmer V, Ivanova G, Rolfe J. Mining developments and social impacts on communities: Bowen basin case studies. Rural Soc. 2009;19:211\u201328.","journal-title":"Rural Soc"},{"key":"4578_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.cmi.2018.03.028","volume":"24","author":"P Shrestha","year":"2018","unstructured":"Shrestha P, Roberts T, Homsana A, Myat TO, Crump JA, Lubell Y, et al. Febrile illness in Asia: gaps in epidemiology, diagnosis and management for informing health policy. Clin Microbiol Infect, 2018;24:815\u201326.","journal-title":"Clin Microbiol Infect"},{"key":"4578_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmi.2018.02.011","volume":"24","author":"MJ Maze","year":"2018","unstructured":"Maze MJ, Bassat Q, Feasey NA, Mandomando I, Musicha P, Crump JA. The epidemiology of febrile illness in sub-saharan Africa: implications for diagnosis and management. Clin Microbiol Infect. 2018;24:808\u201314.","journal-title":"Clin Microbiol Infect"},{"key":"4578_CR34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmi.2018.05.001","volume":"24","author":"J Moreira","year":"2018","unstructured":"Moreira J, Bressan CS, Brasil P, Siqueira AM. Epidemiology of acute febrile illness in Latin America. Clin Microbiol Infect. 2018;24:827\u201335.","journal-title":"Clin Microbiol Infect"},{"key":"4578_CR35","doi-asserted-by":"publisher","first-page":"e0007927","DOI":"10.1371\/journal.pntd.0007927","volume":"14","author":"MH Gasem","year":"2020","unstructured":"Gasem MH, Kosasih H, Tjitra E, Alisjahbana B, Karyana M, Lokida D, et al. An observational prospective cohort study of the epidemiology of hospitalized patients with acute febrile illness in Indonesia. PLoS Negl Trop Dis. 2020;14:e0007927.","journal-title":"PLoS Negl Trop Dis"},{"key":"4578_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12879-016-2025-x","volume":"16","author":"J Stoler","year":"2016","unstructured":"Stoler J, Awandare GA. Febrile illness diagnostics and the malaria-industrial complex: a socio-environmental perspective. BMC Infect Dis. 2016;16:683.","journal-title":"BMC Infect Dis"},{"key":"4578_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-14-1","volume":"14","author":"MM Thandar","year":"2015","unstructured":"Thandar MM, Kyaw MP, Jimba M, Yasuoka J. Caregivers\u2019 treatment-seeking behaviour for children under age five in malaria-endemic areas of rural Myanmar: a cross-sectional study. Malar J. 2015;14:1.","journal-title":"Malar J"},{"key":"4578_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.4269\/ajtmh.2009.08-0361","volume":"81","author":"RE Mujica Mota","year":"2009","unstructured":"Mujica Mota RE, Lara AM, Kunkwenzu ED, Lalloo DG. Health seeking behavior after fever onset in a malaria-endemic area of Malawi. Am J Trop Med Hyg. 2009;81:935\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"4578_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1475-2875-8-173","volume":"8","author":"SM Ahmed","year":"2009","unstructured":"Ahmed SM, Haque R, Haque U, Hossain A. Knowledge on the transmission, prevention and treatment of malaria among two endemic populations of Bangladesh and their health-seeking behaviour. Malar J. 2009;8:173.","journal-title":"Malar J"},{"key":"4578_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41182-017-0070-9","volume":"45","author":"PA Naing","year":"2017","unstructured":"Naing PA, Maung TM, Tripathy JP, Oo T, Wai KT, Thi A. Awareness of malaria and treatment-seeking behaviour among persons with acute undifferentiated fever in the endemic regions of Myanmar. Trop Med Health. 2017;45:31.","journal-title":"Trop Med Health"},{"key":"4578_CR41","doi-asserted-by":"publisher","first-page":"e80343","DOI":"10.1371\/journal.pone.0080343","volume":"8","author":"C Gryseels","year":"2013","unstructured":"Gryseels C, Uk S, Erhart A, Gerrets R, Sluydts V, Durnez L, et al. Injections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast Cambodia. PLoS One. 2013;8:e80343.","journal-title":"PLoS One"},{"key":"4578_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-7-148","volume":"7","author":"M Karyana","year":"2008","unstructured":"Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008;7:148.","journal-title":"Malar J"},{"key":"4578_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4269\/ajtmh.17-0662","volume":"98","author":"JR Poespoprodjo","year":"2018","unstructured":"Poespoprodjo JR, Kenangalem E, Wafom J, Chandrawati F, Puspitasari AM, Ley B, et al. Therapeutic response to dihydroartemisinin-piperaquine for P. falciparum and P. vivax nine years after its introduction in southern Papua, Indonesia. Am J Trop Med Hyg. 2018;98:677\u201382.","journal-title":"Am J Trop Med Hyg"},{"key":"4578_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.sapharm.2006.10.004","volume":"3","author":"WR Brieger","year":"2007","unstructured":"Brieger WR, Salami KK, Oshiname FO. Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria. Res Soc Adm Pharm. 2007;3:303\u201319.","journal-title":"Res Soc Adm Pharm"},{"key":"4578_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/00140139.2017.1349935","volume":"61","author":"D Tao","year":"2018","unstructured":"Tao D, Wang T, Wang T, Qu X. Influence of drug colour on perceived drug effects and efficacy. Ergonomics. 2018;61:284\u201394.","journal-title":"Ergonomics"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04578-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04578-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:04:51Z","timestamp":1684555491000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04578-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4578"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04578-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1760602\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial and the mixed-methods study were conducted according to the principles stated in the Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects) as amended in 2008, all applicable regulations and according to established international scientific standards. The study protocol was reviewed and approved by the ethical committees of the Faculty of Medicine Gadjah Mada University in Indonesia (KE\/FK\/522\/EC\/2016), the Human Research Ethics Committee (HREC) of the Northern Territory (NT) Department of Health and Menzies School of Health Research in Australia (15-2517), and the Institute of Tropical Medicine in Belgium (1163\/17). For the qualitative strand, oral consent was collected from all participants and, for minors, from a legal guardian. For the quantitative survey, written informed consent was obtained from all participants or legal guardians in case they were underage. Illiterate participants willing to participate provided consent by a fingerprint in the presence of a witness.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}